AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Optimism in Gene Therapy Development
This chapter explores the hopeful outlook of pharmaceutical leaders regarding the Trump administration amidst industry cuts, and highlights Solid Biosciences' promising advancements in gene therapy for Duchenne muscular dystrophy. It reflects on the company's resilience through past challenges while navigating a competitive landscape for effective treatment options.